+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Empty Capsules Market set to grow to $2.8bn by 2025” says new Visiongain report

23 January 2020
Pharma

Visiongain has launched a new pharma report Global Empty Capsules Market Report: Gelatin Capsules, Non-gelatin Capsules, Pig Skin Gelatin, Bovine Derived Gelatin, Bone Meal Gelatin, Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, Starch Material, Antibiotic & Antibacterial Drugs, Vitamins & Dietary Supplements, Cough & Cold Preparations, Anti-inflammatory Drugs, Cardiovascular Drugs, Antacid & Antiflatulent Drugs, Antianemic Drugs, Pharmaceutical Industry, Neutraceutical Industry, Cosmetics Industry, Clinical Research Laboratories.

The empty capsules market is a highly competitive and diverse market with immense potential for growth. The growth drivers of this market are ageing population, increasing applications in the pharmaceutical and nutraceutical industries, increasing demand for non-gelatin/HPMC capsules in nutraceutical industry, and market development in emerging countries due to low manufacturing advantage.

The lead analyst of the report commented "The non-gelatin capsules segment is estimated to grow at the highest CAGR during the forecast period. Strict government regulations, dietary sensitivity of patients, and drug incompatibilities with gelatin capsules are the major factors driving the growth of the non-gelatin capsules segment. the growing demand for non-gelatin-based capsules and the rapidly expanding pharmaceutical industry in emerging countries such as India and China offer significant growth opportunities for players in this market."

Leading companies featured in the report include ACG Worldwide, Bright Pharmacaps Inc., CapsCanada Corporation, Capsugel (Lonza), Healthcaps India Ltd., Medicaps Ltd., Natural Capsules Limited and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read